Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Biotech
Pfizer pulls the plug on 11 programs
Pfizer has axed 11 programs including two pipeline assets from its Seagen buy, work on a BioNTech-partnered mRNA vaccine and a midstage MASH combo.
Gabrielle Masson
Nov 4, 2025 2:40pm
BMS removes 2 clinical programs from pipeline
Oct 30, 2025 1:14pm
GSK says 'stay tuned' for more ADC data as Hansoh posts 49% ORR
Oct 19, 2025 10:40am
Takeda turns to AI drug designer after whittling down R&D focus
Oct 14, 2025 5:00am
Sanofi inks pact with Canadian tech company to bring AI to R&D
Oct 8, 2025 12:13pm
Takeda lays off 137 US staff as part of cell therapy retreat
Oct 1, 2025 3:13pm
